Dylann Fujimoto

A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes

M. Azoulay, Iris C. Gibbs, Steven Hancock et al. · Neuro-Oncology · 2020 · 63 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival

Erqi L. Pollom, Dylann Fujimoto, Summer S. Han et al. · Journal of Radiation Research · 2018 · 52 citations · Full text

Medicine, Oncology, Surgery +17

Recurrence risk factors in stage IA grade 1 endometrial cancer

Chika Nwachukwu, Mana Baskovic, Rie von Eyben et al. · Journal of Gynecologic Oncology · 2021 · 35 citations · Full text

Medicine, Gynecology, Oncology +11

Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur

Dylann Fujimoto, Rie von Eyben, Iris C. Gibbs et al. · Journal of Neuro-Oncology · 2017 · 26 citations

Medicine, Neurosurgery, Radiology +15

Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors

Alexander L. Chin, Dylann Fujimoto, Kiran A. Kumar et al. · Neurosurgery · 2018 · 26 citations

Medicine, Neurosurgery, Oncology +14